A New Twist on Dx Distribution
This article was originally published in Start Up
Avocet Medical Inc., a six-year old start-up company, has come up with an innovative solution for marketing its first product, a point-of-care pro-thrombin testing system for monitoring patients on oral anticoagulation therapy. Avocet plans to sell it through Olsten Home Health Care, recently renamed Gentiva Health Services Inc., in a two-part deal that allows it to reach both doctors and patients.
You may also be interested in...
Fractyl Health closed a $100m financing round to support ongoing development of duodenal mucosal resurfacing (DMR) technology that addresses root causes of type 2 diabetes. CEO Harith Rajagopalan spoke of his hopes for the technology.
The ‘sea change’ inside White Oak should be seen as very encouraging for sponsors, FDA official says.
Foreign facility visits may take longer to reach usual levels because of the ongoing coronavirus outbreaks in other countries.